Reagents were obtained from the following sources: [1,2-3H]-taurine and [α-32P]-dCTP (Amersham Pharmacia Biotech, Piscataway, NJ); [2,3-3H(N)]-γ aminobutyric acid (GABA; Dupont/NEN, Boston, MA); [3H(N)]-carnitine, [4,5-3H]-leucine, and [2-3H]-myo-inositol (Moravek Biochemicals, Brea, CA); taurine, myo-inositol, GABA, succinyl concanavalin A (sConA), and anti-β actin antibody (Sigma-Aldrich, St. Louis, MO); DMEM-F12 medium (catalog no. 12320), extraction reagent (TRIzol), and penicillin-streptomycin (Gibco-Invitrogen Corp., Grand Island, NY); fetal bovine serum (FBS; Atlanta Biologicals, Atlanta, GA); ARPE-19 cells (ATCC, Manassas, VA); rat ganglion cells RGC-5 (Neeraj Agarwal, University of North Texas Health Science Center, Fort Worth, TX); rat Müller cells rMC-1 (Vijay Sarthy, Northwestern University, Chicago, IL); antibody against rat TauT and the immunogenic control peptide (Alpha Diagnostics, Inc., San Antonio, TX); FITC-conjugated anti-rabbit IgG (AffiniPure; Jackson ImmunoResearch Laboratories, West Grove, PA); HRP-conjugated goat anti-rabbit IgG, and an enhanced chemiluminescence (ECL) detection kit (Santa Cruz Biotechnology, Santa Cruz, CA); protease inhibitor cocktail (Complete Mini Tablets; Roche Applied Science, Indianapolis, IN); RNA PCR core kit (Perkin-Elmer, Boston, MA); hybridization solution (ExpressHyb; Clontech, Palo Alto, CA); and ultrasensitive hybridization buffer (ULTRAHyb; Ambion, Austin, TX).